Stroke Trial, Recruiting NCT07302971 Sponsor: Capital Medical University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07302971
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Regarding the hospital:

  • The hospital must be a basic-level or county-level hospital in China, classified as Grade II or below under China's hospital grading system
  • The hospital must have an emergency department and a neurology ward that can care for stroke patients
  • The hospital must have CT and/or MRI scanning equipment able to diagnose acute ischemic stroke
  • The hospital must have the appropriate clot-dissolving medications available for treating acute ischemic stroke

Regarding the patient:

  • Adults aged 18 or older
  • People who have been diagnosed with an acute ischemic stroke (a stroke caused by a blockage, not bleeding)
  • People whose brain scan confirms there is no bleeding in the brain
  • People whose stroke symptoms started no more than 4.5 hours before treatment
  • People who were largely independent in daily life before the stroke (confirm with trial site)
  • People for whom written agreement to participate has been given by the patient or their legal representative

Who may not be able to join:

Regarding the hospital:

  • Hospitals that treat fewer than 10 acute ischemic stroke patients per month
  • Hospitals already taking part in other clinical trials that could interfere with this one

Regarding the patient:

  • People for whom clot-dissolving treatment is considered medically unsuitable, based on international stroke treatment guidelines (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01083198962

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Capital Medical University
Registry
ClinicalTrials.gov
Start date
2 February 2026
Est. completion
1 June 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Proportion of patients with mRS scores of 0-1

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov